Contribution of vascular catheter material to the pathogenesis of infection: Depletion of complement by silicone elastomer in vitro

Journal of Biomedical Materials Research

Volumn 30, Issue 2, 1996, Pages 245-250

  Marosok, Randy ^a   Washbum, Ronald ^b   Indorf, Amy ^c   Solomon, Donald ^d   Shetertz, Robert ^b  

^a Lentini Health Center   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Infectious Disease Service   (United States)

^d BD Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETERS; CONTAMINATION; ELASTOMERS; IMPLANTS (SURGICAL); POLYURETHANES; POLYVINYL CHLORIDES; SILICONES;

CHEMOTACTIC GRADIENT; PATHOGENESIS; STAPHYLOCOCCUS AUREUS; VASCULAR CATHETER;

BIOMATERIALS;

GLASS; POLYURETHAN; POLYVINYLCHLORIDE; SILASTIC; SILICONE;

ARTICLE; BLOOD VESSEL CATHETERIZATION; CATHETER INFECTION; COMPLEMENT ACTIVATION; HUMAN; IN VITRO STUDY; INFECTION RISK; OPSONIZATION; PATHOGENESIS; RADIOIMMUNOASSAY; SERUM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

CATHETERIZATION; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT SYSTEM PROTEINS; CROSS INFECTION; HUMANS; POLYURETHANES; POLYVINYL CHLORIDE; SILICONE ELASTOMERS;

EID: 9044234770     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199602)30:2<245::AID-JBM15>3.0.CO;2-L     Document Type: Article

References (47)

1. P. F. Pollack, M. Kadden, W. J. Byrne, E. W. Fonkalsrud, and M. E. Ament, "100 patient years' experience with the Broviac silastic catheter for central venous nutrition," J. Parenteral Enteral Nutr. 5, 32-36 (1981).
2. O. W. Press, P. G. Ramsey, E. G. Larson, A. Feffer, and R. O. Hickman, "Hickman catheter infections in patients with malignancies," Medicine 63, 189-200 (1994).
3. P. R. Johnson, K. M. Edwards, and P. F. Wright, "Frequency of Broviac catheter infections in pediatric oncology patients," J. Infect. Dis., 154, 570-578 (1986).
4. H. S. Bjornson, R. Colley, R. H. Bower, V. P. Duty, J. T. Schwartz-Fulton, and J. E. Fischer, "Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition," Surgery, 92, 720-726 (1982).
5. J. Linares, A. Sitges-Serra, J. Garau, J. L. Perez, and R. Martin, "Pathogenesis of catheter sepsis: A prospective study with quantitative and semiquantitative cultures on catheter hub and segments," J. Clin. Microbiol., 21, 357-360 (1985).
6. N. C. Weightman, E. M. Simpson, and D. C. E. Speller, "Source of infection in Hickman catheters," J. Clin. Path. 39, 1046 (1986).
7. D. G. Maki, L. Cobb, J. K. Carman, J. M. Shapiro, M. Ringer, and R. B. Helgerson, "An attachable silver-impregnated cuff for prevention of infection with central venous catheters: A prospective randomized multicenter trial," Am. J. Med., 85, 307-314 (1988).
8. R. H. Flowers, K. J. Schwenzer, R. F. Kopel, M. J. Fisch, S. I. Tucker, and B. M. Farr, "Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection: A randomized, controlled trial," J. Am. Med. Assoc., 261, 878-883 (1989).
9. S. D. Elek and P. E. Conen, "The virulence of Staphylococcus pyrogenes for man: A study of the problems of wound infection," Er. J. Exp. Pathol., 38, 573-586 (1957).
10. W. C. Noble, "The production of subcutaneous staphylococcal skin lesions in mice," Br. J. Exp. Pathol., 46, 254-267 (1965).
11. W. Zimmerli, F. A. Waldvogel, P. Vaudaux, and U. E. Nydegger, "Pathogenesis of foreign body infection: Description and characteristics of an animal model," J. Infect. Dis., 146, 487-497 (1982).
12. W. Zimmerli, D. P. Lew, and F. A. Waldvogel, "Pathogenesis of foreign body infection: Evidence for a local granulocyte defect," J. Clin. Invest., 73, 1191-1200 (1984).
13. R. J. Sherertz, W. A. Carruth, A. A. Hampton, M. P. Byron, and D. D. Solomon, "Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits," J. Infect. Dis., 167, 98-106 (1993).
14. R. J. Sherertz, W. A. Carruth, R. D. Marosok, M. Espeland, and D. D. Solomon, "Contribution of vascular catheter material to the pathogenesis of infection: The enhanced risk of silicone elastomer in vivo," J. Biomed. Mater. Res., in press.
15. C. Gerard and N. P. Gerard, "C5a anaphylatoxin and its seven transmembrane-segment receptors," Ann. Rev. Immunol., 12, 775-808 (1994).
16. D. E. Wilson, J. E. Bennett, J. W. Bailey, "Serologic grouping of Cryptococcus neoformans," Proc. Soc. Exp. Biol. Med., 127, 820-823 (1968).
17. R. G. Washburn, C. H. Hammer, and J. E. Bennett, "Inhibition of complement by culture supernatants of Aspergillus fumigatus," J. Infect. Dis., 154, 944-951 (1986).
18. C. H. Hammer, G. H. Wirtz, L. Renter, H. D. Gresham, and B. F. Tack, "Large-scale isolation of functionally active components of the human complement system," J. Biol. Chem., 256, 3995-4006 (1981).
19. M. A. K. Markwell, "A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum," Anal. Biochem., 125, 427-432 (1982).
20. 3H]-thymidine-labeled bacteria," J. Immunol. Meth., 14, 303-311 (1977).
21. P. C. J. Leijh, M. van den Barselaar, I. Dubbeldeman-Rempt, and R. van Furth, "Kinetics of intracellular killing of Staphylococcus aureus and escherichia coli by human granulocytes," Eur. J. Immunol., 10, 750-762 (1980).
22. J. W. Li, and S. Mudd, "The heat-labile serum factor associated with intracellular killing of Staphylococcus aureus," J. Immunol., 94, 852-857 (1965).
23. R. B. Johnston, Jr., M. R. Klemperer, C. A. Alper, and F. S. Rosen, "The enhancement of bacterial phagocytosis by serum," J. Exp. Med., 129, 1275-1290 (1969).
24. J. Verhoef, P. K. Peterson, Y. Kim, L. D. Sabbath, and P. G. Quie, "Opsonic requirements for staphylococcal phagocytosis: Heterogeneity among stains," Immunology, 33, 191-197 (1965).
25. W. B. Wood, M. R. Smith, and B. Watson, "Studies on the mechanism of recovery in pneumococcal pneumonia. IV. The mechanisms of phagocytosis in the absence of antibody," J. Exp. Med., 84, 387-401 (1946).
26. W. B. Wood, M. R. Smith, W. D. Perry, and J. W. Berry, "Studies on the cellular immunology of acute bacteremia. I. Intravascular leukocyte reaction and surface phagocytosis," J. Exp. Med., 94, 521-533.
27. D. A. Lee, J. R. Hoidal, C. C. Clawson, P. G. Quie, and P. K. Peterson, "Phagocytosis by polymorphonuclear leukocytes of Staphylococcus aureus and Pseudomonas aeruginosa adherent to plastic, agar, or glass," J. Immunol. Meth., 63, 103-114 (1983).
28. D. L. Gordon and J. L. Rice, "Opsonin-dependent and independent surface phagocytosis of Staphylococcus aureus proceeds independently of complement and complement receptors," Immunology 64, 709-714 (1988).
29. D. L. Gordon, V. M. Avery, J. L. Rice, and P. J. McDonald, "Surface phagocytosis of Staphylococcus epidermidis and Escherichia coli by human neutrophils: Serum requirements for opsonization and chemiluminescence," Fems. Microbiol. Immunol., 1, 417-423 (1989).
30. V. M. Avery and D. L. Gordon, "Antibacterial properties of breast milk: Requirements for surface phagocytosis and chemiluminescence," Eur. J. Clin. Microbiol. Infect. Dis., 10, 1034-1039 (1991).
31. J. Fehr and C. Dahinden, "Modulating influence of chemotactic factor-induced adhesiveness on granulocyte function," J. Clin. Invest., 64, 8-16 (1979).
32. H. N. Fernandez, P. M. Henson, A. Otani, and T. E. Hugli, "I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions," J. Immunol., 120, 109-115 (1978).
33. des Arg on neutrophil function," Immunopharmacology, 2, 201-219.
34. P. R. Craddock, J. Fehr, A. P. Dalmasso, K. I. Brigham, and H. S. Jacob, "Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membrane," J. Clin. Invest., 59, 879-888 (1977).
35. P. R. Craddock, J. Fehr, K. L. Brigham, R. S. Kronenberg, and H. S. Jacob, "Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis," N. Engl. J. Med., 296, 769-774 (1977).
36. V. I. Sevast'ianov and E. A. Tseytlina, "The activation of the complement system by polymer materials and their blood compatibility," J. Biomed. Mater. Res., 18, 969-978 (1984).
37. D. E. Chenoweth, "Biocompatibility of hemodialysis membranes: Evaluation with C3a anaphylatoxin RIA," ASAIO J., 7, 44-49 (1984).
38. D. E. Chenoweth, "Complement activation produced by biomaterials," Trans. Am. Soc. Artif. Intern. Org., 32, 226-232 (1986).
39. P. Garred, J. Olsen, T. E. Mollnes, T. Bilde, and B. E. Glahn, "Biocompatability of urinary catheters: Effect on complement activation," Br. J. Urol., 63, 367-371 (1989).
40. G. S. Herzlinger, D. H. Bing, R. Stein, and R. D. Gumming, "Quantitative measurement of C3a activation at polymer surfaces," Blood, 57, 764-770 (1981).
41. M. K. Pangburn, D. C. Morrison, R. K. Schreiber, and H. J. Müeller-Eberhard, "Activation of the alternative complement pathway: Recognition of surface structures on activators by bound C3b," J. Immunol. 124, 977-982 (1980).
42. S. K. Law, N. A. Lichtenberg, and R. P. Levine, "Evidence of an ester linkage between the labile binding site of C3b and receptor surfaces," J. Immunol., 123, 1388-1394 (1979).
43. M K. Pangburn and H. J. Müeller-Eberhard, "Relation of a putative thioester bond in C3 activation of the alternate pathway and the binding of C3b to biological targets of complement," J. Exp. Med., 152, 1102-1114 (1980).
44. D. E. Chenoweth, "Complement activation during hemodialysis: Clinical observations, proposed mechanisms, and theoretical implications," Artif. Organs, 8, 281-287 (1984).
45. W. Noll, "Chemistry and Technology of Silicones," Academic Press, San Diego, 1968.
46. J. Janatova, A. K. Cheung, C. J. Parker, "Biomedical polymers differ in their capacity to activate complement," Comp. Inflamm, 8, 61-69 (1991).
47. R. M. Hakim, "Complement activation by biomaterials," Cardiovasc. Pathol., 2, 187S-197S (1993).